A carregar...

Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics

BACKGROUND: Non-adherence to antipsychotic therapy among patients with schizophrenia is a key driver of relapse, which can lead to costly inpatient stays. Long-acting injectables (LAIs) may improve adherence, thus reducing hospitalizations, but inpatient cost reductions need to be balanced against h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Real World Outcomes
Main Authors: Pesa, Jacqueline A., Muser, Erik, Montejano, Leslie B., Smith, David M., Meyers, Oren I.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674518/
https://ncbi.nlm.nih.gov/pubmed/26689953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-015-0043-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!